Andromedic
Andromedic S.r.l. is an Italian medical device company that develops and distributes the HY-DEEP 600WM, a deep capacitive radiofrequency oncological hyperthermia system sold to hospitals, oncology clinics, and cancer treatment centers worldwide through regional distributors and direct enterprise sales.
- Company typePrivate
- Founded2012
- HeadquartersVelletri, Italy
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Andromedic does
Andromedic S.r.l. is an Italian medical device company that develops, manufactures, and distributes advanced equipment for deep oncological hyperthermia. Founded in 1994 as Andromedic Italia and spun off in 2012 as a separate entity focused on hyperthermia, the company is headquartered in Velletri (Rome), Italy, and operates as a private limited company with no disclosed external funding. Its flagship product is the HY-DEEP 600WM, a deep capacitive radiofrequency system operating at 13.56 MHz that delivers high-intensity electromagnetic pulses combined with a bio-resonance effect to target solid tumors. The device features patented water-cooled antennas (170mm and 270mm), a Thermal Modulation System using ASK modulation in OOK mode, and dedicated software with indirect temperature calculation algorithms. Andromedic sells to hospitals, oncology clinics, and cancer treatment centers globally through a network of regional distributors covering Asia, the Middle East, Europe, and South Korea, supplemented by direct enterprise sales. Revenue is generated through three models: equipment sales, equipment rental (monthly fee or pay-per-use), and equipment leasing through a financial partnership with BCC Lease. The company holds ISO 13485:2016, CE, Korean GMP, and Korean MFDF certifications, and is governed by three co-founders: Ciro Zaccagnini (President), Ivano Zaccagnini (Production Manager), and Salvatore Conte (Sales Manager and Scientific Director).
Andromedic firmographics
Firmographics- Name
- Andromedic
- Legal name
- Andromedic S.r.l.
- Website
- https://andromedic.it
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Short description
- Andromedic S.r.l. is an Italian medical device company that develops and distributes the HY-DEEP 600WM, a deep capacitive radiofrequency oncological hyperthermia system sold to hospitals, oncology clinics, and cancer treatment centers worldwide through regional distributors and direct enterprise sales.
- Ownership category
- akta.pro rank
Andromedic industry classification
Industry- Product category
- Oncological Hyperthermia Medical Devices
- NAICS
- Irradiation Apparatus Manufacturing (334517), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH)
Keywords
Where Andromedic is headquartered
LocationHeadquarters
- HQ city
- Velletri
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
Andromedic business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Medical Equipment Sales: Sale of HY-DEEP 600WM oncological hyperthermia equipment to healthcare facilities, hospitals, and oncology clinics worldwide
- Equipment Rental: Flexible rental solutions including monthly fee option for predictable cost management and pay-per-use option based on individual treatments performed. Custom rental solutions available.
- Equipment Leasing/Financing: Leasing and customized financing solutions in partnership with BCC Lease to support private healthcare facilities and medical professionals in acquiring equipment while spreading costs over time
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Monthly rental fee option |
| Usage-based | Pay-as-you-go | Pay-per-use rental option |
| Other | Multi-year contract | Equipment purchase with leasing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Andromedic product offering
Product offeringCore offering
Andromedic designs, manufactures, and distributes the HY-DEEP 600WM, a deep capacitive radiofrequency oncological hyperthermia device operating at 13.56 MHz. The system delivers high-intensity electromagnetic pulses combined with a bio-resonance effect to raise tumor tissue temperature to 42.5–43°C as an adjuvant or neo-adjuvant to radiotherapy and chemotherapy, and is sold bundled with patented cooled antennas, dedicated treatment software, and a therapy management PC. Equipment is offered through direct purchase, monthly rental, pay-per-use rental, or BCC Lease-financed leasing to hospitals, oncology clinics, and cancer treatment centers worldwide.
Product overview
Andromedic specializes in developing and manufacturing advanced oncological hyperthermia solutions. The company's flagship product is the HY-DEEP 600WM system, a deep capacitive radiofrequency medical device designed for non-invasive oncological hyperthermia treatment. The system combines electromagnetic wave pulses with bio-resonance technology to target and treat tumors. Andromedic provides complete solutions including proprietary software with automated treatment delivery, patented cooled antennas (170mm and 270mm), antenna spacers, and high-performance PC for treatment management. The equipment is offered through purchase or flexible rental options with financing partnerships.
Differentiator
Problem solved
Functional benefit
Products and services
- HY-DEEP 600WM The HY-DEEP 600WM is a deep capacitive radiofrequency oncological hyperthermia device that generates high-intensity electromagnetic pulses at 13.56 MHz combined with a bio-resonance effect to raise target organ or tissue temperature. It is intended as an adjuvant or neo-adjuvant therapy for neoplastic pathologies and concomitant conditions such as infections, inflammation, and pain, and is delivered with patented cooled antennas (170mm and 270mm), antenna spacers, dedicated therapy software with automated data archiving, an indirect temperature calculation algorithm, and a high-performance therapy management PC. The product is sold to hospitals, oncology clinics, and cancer treatment centers and is offered via purchase, monthly rental, pay-per-use rental, or BCC Lease-financed leasing.
Quantifiable outcome
- Therapeutic response improvement of approximately 35% when hyperthermia is added to radiotherapy or chemotherapy
- +1 more outcomes
Companies that use Andromedic
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Andromedic technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Andromedic partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- VL Holdings LimitedcoreExclusive distributor for Thailand, Vietnam, Malaysia, Singapore, and UAE markets. Located at 65 Julia Street, OCBC Center, Singapore, handling sales and distribution of HY-DEEP 600WM equipment in Southeast Asia and Middle East regions.
- SMMedicare IncorporatedcoreExclusive distributor for South Korea. Located at Hallim Human Tower, Gunpo-si, Gyeonggi-do, Republic of Korea. Contact: +82 (0)31 458-3188, [email protected]
- EMIRAL Congress Bureau, S.L.coreDistributor for Spain market. Located at Avenida Gran Capitán 46, 2ª, Oficina 4, 14006 Córdoba, Spain. Contact: (+34) 957 080 733, [email protected]
- MAG Biotech Trading Co., Ltd.minorDistributor for Taiwan market. Located at 7F-5, No. 205, Sec. 1, Dunhua S. Rd., Da'an Dist., Taipei City 10690, Taiwan (R.O.C.)
- LOGNORD TECHNOLOGY s.r.o.minorDistributor for Slovakia and Czech Republic. Located at A.Stefanku 6/1, 96501 Žiar nad Hronom, Slovakia. Contact: (+421) 905 202 805, [email protected], represented by Ing. Martin Ľupták, PhD.
Scale indicators2 records
Recent moves7 records
Expansion highlights5 records
Andromedic competitors and assessment
Company assessmentDirect peers
- Oncotherm: Oncotherm develops capacitive radiofrequency systems for oncological hyperthermia. It is a direct peer because it addresses the same oncology customers and treatment category using a closely related energy-delivery architecture.
- Pyrexar Medical: Pyrexar Medical provides deep and superficial hyperthermia systems and applicators for cancer treatment. It is directly comparable as a specialist supplier of hospital-based thermal oncology equipment, although its core deep-heating architecture differs from Andromedic's capacitive RF approach.
- Celsius42: Celsius42 develops specialist medical hyperthermia systems for oncology providers. It is a direct peer because it targets the same energy-based cancer-treatment category and hospital equipment purchasing motion.
- Yamamoto Co., Ltd. Yamamoto Co. develops and supplies radiofrequency capacitive hyperthermia equipment for oncological treatment. It is closely comparable to Andromedic in modality, customer type, and product positioning.
Emerging players
- Hydrosun: Hydrosun provides water-filtered infrared-A hyperthermia systems for medical use. It overlaps with Andromedic in hospital-based oncological heating equipment, but focuses more on local or superficial treatment rather than deep capacitive RF delivery.
- MagForce AG: MagForce develops NanoTherm therapy, which uses magnetic nanoparticles to generate localized tumor heating. It is comparable as a specialist thermal-oncology technology company serving cancer centers, although its delivery mechanism is materially different.
- Profound Medical: Profound Medical commercializes the TULSA-PRO platform for MRI-guided transurethral ultrasound ablation of prostate tissue. It is an emerging peer in hospital-based thermal cancer treatment, with a different anatomical focus and energy-delivery mechanism.
- EDAP TMS: EDAP TMS develops focused-ultrasound platforms used in urology and other therapeutic applications. It competes for similar clinical budgets and oncology equipment relationships, but delivers treatment through high-intensity focused ultrasound rather than radiofrequency hyperthermia.
- Novocure: Novocure provides Tumor Treating Fields therapy to oncology patients and providers. It is comparable in the broader electromodulation and cancer-treatment market, although it uses a nonthermal, wearable electric-field platform rather than hospital hyperthermia equipment.
Broad incumbents
- Elekta: Elekta is an established provider of radiation-therapy and oncology-care systems. It is a broad incumbent because it overlaps with Andromedic in radiation-oncology budgets and hospital workflows, but does not specialize in hyperthermia.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Andromedic social profiles
Digital presenceAndromedic compliance and trust
Trust signalCompliance4 records
Andromedic financial estimates
Financial estimateRevenue estimate
Valuation estimate
Andromedic leadership team
Management profileNumber of profiles
Profiles4 records
Andromedic funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Andromedic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Andromedic
What does Andromedic do?
Andromedic designs, manufactures, and distributes the HY-DEEP 600WM, a deep capacitive radiofrequency oncological hyperthermia device operating at 13.56 MHz. The system delivers high-intensity electromagnetic pulses combined with a bio-resonance effect to raise tumor tissue temperature to 42.5–43°C as an adjuvant or neo-adjuvant to radiotherapy and chemotherapy, and is sold bundled with patented cooled antennas, dedicated treatment software, and a therapy management PC. Equipment is offered through direct purchase, monthly rental, pay-per-use rental, or BCC Lease-financed leasing to hospitals, oncology clinics, and cancer treatment centers worldwide.
Is Andromedic a public or private company?
Andromedic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Andromedic founded?
Andromedic was founded in 2012.
Where is Andromedic based?
Andromedic is headquartered in Velletri, Italy, in the Europe region.
How does Andromedic make money?
Three revenue lines are on record. Medical Equipment Sales are the primary driver. The others are equipment Rental and equipment Leasing/Financing.
Who are Andromedic's main competitors?
Direct peers on record are Oncotherm, Pyrexar Medical, Celsius42 and Yamamoto Co., Ltd.. Emerging players are Hydrosun, MagForce AG, Profound Medical, EDAP TMS and Novocure. Elekta is listed as a broad incumbent.
Does Andromedic have an API?
No public API is recorded for Andromedic.
What industry is Andromedic in?
Andromedic's product category is Oncological Hyperthermia Medical Devices. Its primary akta.pro industry code is HLAHABAH, Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim). Its NAICS code is 334517 and its SIC code is 3845.